BSE: JBCHEPHARM - J. B. Chemicals & Pharmaceuticals Limited

Rentabilidade por seis meses: -20.19%
Rendimento de dividendos: +0.73%

Cronograma de promoção J. B. Chemicals & Pharmaceuticals Limited


Sobre a empresa J. B. Chemicals & Pharmaceuticals Limited

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.

mais detalhes
It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.

ISIN INE572A01028
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.6872
Дивиденд ао 15.25
Сайт https://www.jbpharma.com
Цена ао 1518
Alteração de preço por semana: -3.77% (1577.4)
Alteração de preço por mês: -6.72% (1627.3)
Alteração de preço em 3 meses: -17.54% (1840.85)
Mudança de preço em seis meses: -20.19% (1902)
Mudança de preço por ano: -2.02% (1549.25)
Mudança de preço em 3 anos: -3.32% (1570.1)
Mudança de preço em 5 anos: +205.74% (496.5)
Mudança de preço desde o início do ano: -20.65% (1912.95)

Subestimação

Nome Significado Nota
P/S 7.25 1
P/BV 8.55 1
P/E 45.21 3
EV/EBITDA 5.46 9
Total: 5.13

Eficiência

Nome Significado Nota
ROA, % 14.64 4
ROE, % 20.45 7
Total: 6.33

Dividendos

Nome Significado Nota
Div yield, % 0.729 1.83
DSI 0.8571 8.57
Total: 3.75

Obrigação

Nome Significado Nota
Debt/EBITDA 0.124 10
Total: 9.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 97.83 9
Rentabilidade Ebitda, % 731 10
Rentabilidade EPS, % 106.67 10
Total: 9.8

Supervisor Cargo Pagamento Ano de nascimento
Mr. Nikhil Ashokkumar Chopra CEO & Whole-Time Director 65.45M 1973 (52 ano)
Mr. Kunal Khanna President of Operations N/A 1980 (45 anos)
Mr. Sridhar Bharadwaj Vice President of HR & Administration N/A 1967 (58 anos)
Mr. Pradeep Kumar Singh President of Global Business N/A 1964 (61 ano)
Mr. Himanshu Ranvah Vice President of Legal N/A 1985 (40 anos)
Mr. Parmeshwar B. Bang Executive Vice President of Operations of Daman N/A 1968 (57 anos)
Suresh Amin Assistant Vice President ? Human Resource
Mr. Narayan Saraf Chief Financial Officer 1980 (45 anos)
Mr. Bhagwat Singh Deora Vice President of Finance & Accounts 1982 (43 ano)
Mr. Suresh Bhise Vice President of Information & Technology 1966 (59 anos)

Endereço: India, Mumbai, Cnergy IT Park - abrir no Google Maps, abrir mapas Yandex
Site: https://www.jbpharma.com